TIAA CREF Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$272K Buy
2018
Q4
$247K Sell
2018
Q3
$463K Sell
2018
Q2
$590K Buy
2018
Q1
$445K Buy
2017
Q4
$395K Buy
2017
Q3
$332K Buy
2017
Q2
$455K Buy